Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo

Stem Cells and Development

Volumn 22, Issue 23, 2013, Pages 3114-3127

  Mandel, Katharina ^a   Yang, Yuanyuan ^a   Schambach, Axel ^a   Glage, Silke ^a   Otte, Anna ^a   Hass, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; THY 1 ANTIGEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL EXPANSION; CELL INTERACTION; CELL POPULATION; CELL STRUCTURE; CELL VIABILITY; COCULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; TUMOR BURDEN;

EID: 84888614545     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0249     Document Type: Article

References (66)

1. Friedl P and S Alexander. (2011). Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992-1009.
2. Hanahan D and RA Weinberg. (2011). Hallmarks of cancer: the next generation. Cell 144:646-674.
3. Chaturvedi S and R Hass. (2011). Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Mech Ageing Dev 132:213-219.
4. Ungefroren H, S Sebens, D Seidl, H Lehnert and R Hass. (2011). Interaction of tumor cells with the microenvironment. Cell Commun Signal 9:18.
5. Grisendi G, R Bussolari, E Veronesi, S Piccinno, JS Burns, G De Santis, P Loschi, M Pignatti, F Di Benedetto, et al. (2011). Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res 1:787-805.
6. El-Haibi CP and AE Karnoub. (2010). Mesenchymal stem cells in the pathogenesis and therapy of breast cancer. J Mammary Gland Biol Neoplasia 15:399-409.
7. Ahn S, J Cho, J Sung, JE Lee, SJ Nam, KM Kim and EY Cho. (2012). The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biol 33:1573-1580.
8. Roman-Perez E, P Casbas-Hernandez, JR Pirone, J Rein, LA Carey, RA Lubet, SA Mani, KD Amos and MA Troester. (2012). Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res 14:R51.
9. Bertram C and R Hass. (2008). MMP-7 is involved in the aging of primary human mammary epithelial cells (HMEC). Exp Gerontol 43:209-217.
10. Bertram C and R Hass. (2009). Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. Mech Ageing Dev 130:657-669.
11. Lindley LE and KJ Briegel. (2010). Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun 399:659-664.
12. Mani SA,W Guo, MJ Liao, EN Eaton, A Ayyanan, AY Zhou, M Brooks, F Reinhard, CC Zhang, et al. (2008). The epithelial- mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
13. Hass R, C Kasper, S Bohm and R Jacobs. (2011). Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12.
14. Hilfiker A, C Kasper, R Hass and A Haverich. (2011). Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbecks Arch Surg 396: 489-497.
15. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
16. Hong L, A Colpan, IA Peptan, J Daw, A George and CA Evans. (2007). 17-Beta estradiol enhances osteogenic and adipogenic differentiation of human adipose-derived stromal cells. Tissue Eng 13:1197-1203.
17. Wolbank S, M van Griensven, R Grillari-Voglauer and A Peterbauer-Scherb. (2010). Alternative sources of adult stem cells: human amniotic membrane. Adv Biochem Eng Biotechnol 123:1-27.
18. Awad HA, YD Halvorsen, JM Gimble and F Guilak. (2003). Effects of transforming growth factor beta1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng 9:1301-1312.
19. De Miguel MP, S Fuentes-Julian, A Blazquez-Martinez, CY Pascual, MA Aller, J Arias and F Arnalich-Montiel. (2012). Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12:574-591.
20. Kachgal S and AJ Putnam. (2011). Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 14:47-59.
21. Ghajar CM, S Kachgal, E Kniazeva, H Mori, SV Costes, SC George and AJ Putnam. (2010). Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res 316:813-825.
22. Sasaki M, R Abe, Y Fujita, S Ando, D Inokuma and H Shimizu. (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180:2581-2587.
23. Hass R and A Otte. (2012). Mesenchymal stem cells as allround supporters in a normal and neoplastic microenvironment. Cell Commun Signal 10:26.
24. Tome M, P Lopez-Romero, C Albo, JC Sepulveda, B Fernandez- Gutierrez, A Dopazo, A Bernad and MA Gonzalez. (2011). miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 18:985-995.
25. Ciuculescu F, M Giesen, E Deak, V Lang, E Seifried and R Henschler. (2011). Variability in chemokine-induced adhesion of human mesenchymal stromal cells. Cytotherapy 13:1172-1179.
26. Klopp AH, L Lacerda, A Gupta, BG Debeb, T Solley, L Li, E Spaeth, W Xu, X Zhang, et al. (2010). Mesenchymal stem cells promote mammosphere formation and decrease Ecadherin in normal and malignant breast cells. PLoS One 5:e12180.
27. Gauthaman K, FC Yee, S Cheyyatraivendran, A Biswas, M Choolani and A Bongso. (2012). Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem 113:2027-2039.
28. Rubio D, J Garcia-Castro, MC Martin, R de la Fuente, JC Cigudosa, AC Lloyd and A Bernad. (2005). Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039.
29. Wang Y, DL Huso, J Harrington, J Kellner, DK Jeong, J Turney and IK McNiece. (2005). Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 7:509-519.
30. Rosland GV, A Svendsen, A Torsvik, E Sobala, E McCormack, H Immervoll, J Mysliwietz, JC Tonn, R Goldbrunner, et al. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69:5331-5339.
31. Torsvik A, GV Rosland, A Svendsen, A Molven, H Immervoll, E McCormack, PE Lonning, M Primon, E Sobala, et al. (2010). Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track-letter. Cancer Res 70:6393-6396.
32. Gruenloh W, A Kambal, C Sondergaard, J McGee, C Nacey, S Kalomoiris, K Pepper, S Olson, F Fierro and JA Nolta. (2011). Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A 17:1517-1525.
33. Meza-Zepeda LA, A Noer, JA Dahl, F Micci, O Myklebost and P Collas. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 12:553-563.
34. Otte A, V Bucan, K Reimers and R Hass. (2013). Mesenchymal stem cells maintain long-term in vitro stemness during explant culture. Tissue Eng Part C Methods [Epub ahead of print]; DOI: 10.1089/ten.tec.2013.0007.
35. Mishra PJ, PJ Mishra, R Humeniuk, DJ Medina, G Alexe, JP Mesirov, S Ganesan, JW Glod and D Banerjee. (2008). Carcinoma- associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68:4331-4339.
36. Martin FT, RM Dwyer, J Kelly, S Khan, JM Murphy, C Curran, N Miller, E Hennessy, P Dockery, et al. (2010). Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 124:317-326.
37. Yan XL, CJ Fu, L Chen, JH Qin, Q Zeng, HF Yuan, X Nan, HX Chen, JN Zhou, et al. (2012). Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 132: 153-164.
38. Battula VL, KW Evans, BG Hollier, Y Shi, FC Marini, A Ayyanan, RY Wang, C Brisken, R Guerra, M Andreeff and SA Mani. (2010). Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28:1435-1445.
39. Hass R and C Bertram. (2009). Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies. J Exp Clin Cancer Res 28:127.
40. De Giorgi U, EN Cohen, H Gao, M Mego, BN Lee, A Lodhi, M Cristofanilli, A Lucci and JM Reuben. (2011). Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow. Cancer Biol Ther 11:812-815.
41. Korkaya H, S Liu and MS Wicha. (2011). Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 121:3804-3809.
42. Lavrentieva A, I Majore, C Kasper and R Hass. (2010). Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal 8:18.
43. Rust S, S Guillard, K Sachsenmeier, C Hay, M Davidson, A Karlsson, R Karlsson, E Brand, D Lowne, et al. (2013). Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type. Mol Cancer 12:11.
44. Donahue HJ, MM Saunders, Z Li, AM Mastro, CV Gay and DR Welch. (2003). A potential role for gap junctions in breast cancer metastasis to bone. J Musculoskelet Neuronal Interact 3:156-161.
45. Mandel K, D Seidl, D Rades, H Lehnert, F Gieseler, R Hass and H Ungefroren. (2013). Characterization of spontaneous and TGF-beta-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel realtime technology. PLoS One 8:e56591.
46. Otte A, G Gohring, D Steinemann, B Schlegelberger, S Groos, F Langer, HH Kreipe, A Schambach, T Neumann, et al. (2012). A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type. Int J Oncol 41:765-775.
47. Majore I, P Moretti, R Hass and C Kasper. (2009). Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 7:6.
48. Yegorov YE, SS Akimov, R Hass, AV Zelenin and IA Prudovsky. (1998). Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp Cell Res 243:207-211.
49. Sasser AK, BL Mundy, KM Smith, AW Studebaker, AE Axel, AM Haidet, SA Fernandez and BM Hall. (2007). Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254:255-264.
50. Sosnoski DM, V Krishnan, WJ Kraemer, C Dunn-Lewis and AM Mastro. (2012). Changes in cytokines of the bone microenvironment during breast cancer metastasis. Int J Breast Cancer 2012:160265.
51. Gregory LA, RA Ricart, SA Patel, PK Lim and P Rameshwar. (2011). microRNAs, gap junctional intercellular communication and mesenchymal stem cells in breast cancer metastasis. Curr Cancer Ther Rev 7:176-183.
52. Patel SA, SH Ramkissoon, M Bryan, LF Pliner, G Dontu, PS Patel, S Amiri, SR Pine and P Rameshwar. (2012). Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep 2:906.
53. Roorda BD, A Elst, TG Boer, WA Kamps and ES de Bont. (2010). Mesenchymal stem cells contribute to tumor cell proliferation by direct cell-cell contact interactions. Cancer Invest 28:526-534.
54. Xia Y and S Nawy. (2003). The gap junction blockers carbenoxolone and 18beta-glycyrrhetinic acid antagonize conedriven light responses in the mouse retina. Vis Neurosci 20:429-435.
55. Haeryfar SM and DW Hoskin. (2004). Thy-1: more than a mouse pan-T cell marker. J Immunol 173:3581-3588.
56. Karnoub AE, AB Dash, AP Vo, A Sullivan, MW Brooks, GW Bell, AL Richardson, K Polyak, R Tubo and RA Weinberg. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563.
57. Johnson-Holiday C, R Singh, E Johnson, S Singh, CR Stockard, WE Grizzle and JW Lillard, Jr. (2011). CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol 38:1279-1285.
58. Zhang Y, F Yao, X Yao, C Yi, C Tan, L Wei and S Sun. (2009). Role of CCL5 in invasion, proliferation and proportion of CD44 + /CD24 - phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep 21:1113-1121.
59. Del Papa B, P Sportoletti, D Cecchini, E Rosati, C Balucani, S Baldoni, K Fettucciari, P Marconi, MF Martelli, F Falzetti and M Di Ianni. (2013). Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction. Eur J Immunol 43:182-187.
60. Dovey HF, V John, JP Anderson, LZ Chen, P de Saint Andrieu, LY Fang, SB Freedman, B Folmer, E Goldbach, et al. (2001). Functional gamma-secretase inhibitors reduce betaamyloid peptide levels in brain. J Neurochem 76:173-181.
61. Geling A, H Steiner, M Willem, L Bally-Cuif and C Haass. (2002). A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 3:688-694.
62. Sanchez-Dominguez R, S Pereira-Mendez, A Gomez, M Torrabadella, C Azqueta, S Querol, J Barquinero and R Gimeno. (2012). Notch signals contribute to preserve the multipotentiality of human CD34( + )CD38( - )CD45RA( - ) CD90( + ) hematopoietic progenitors by maintaining T cell lineage differentiation potential. Exp Hematol 40:983-993.e4.
63. Henry LA, DA Johnson, D Sarrio, S Lee, PR Quinlan, T Crook, AM Thompson, JS Reis-Filho and CM Isacke. (2011). Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome. Oncogene 30:1046-1058.
64. He J, Y Liu, T Zhu, J Zhu, F Dimeco, AL Vescovi, JA Heth, KM Muraszko, X Fan and DM Lubman. (2012). CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Mol Cell Proteomics 11:M111.010744.
65. Pawelek JM and AK Chakraborty. (2008). Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8:377-386.
66. Rappa G, J Mercapide and A Lorico. (2012). Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am J Pathol 180:2504-2515.